Lv5
820 积分 2024-04-22 加入
The global patent landscape of bispecific antibodies: technological innovations and therapeutic applications
3天前
已完结
Bicyclic Peptide Makes Targeting EphA2 Possible
5天前
已完结
De novo design of miniproteins targeting GPCRs
5天前
已完结
The past, present and future of de novo protein design
5天前
已完结
Off-target reactivity in clinical monoclonal antibodies
5天前
已完结
Macrophages: Targets for next-generation cancer immunotherapy
5天前
已完结
Structure-based calculation of excipient effects on the viscosity of concentrated antibody solutions
5天前
已完结
Novel bispecific T-cell engagers overcoming acquired EGFR resistance
5天前
已完结
A logic-gated trispecific engager enhances macrophage killing of cancer cells in solid tumors
5天前
已完结
Peptide-based drug discovery: Current status and recent advances
6天前
已完结
皖公网安备34019202002308
